These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 17485205

  • 1. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 2: structure-activity relationship studies on the benzopyran scaffold.
    Richardson TI, Norman BH, Lugar CW, Jones SA, Wang Y, Durbin JD, Krishnan V, Dodge JA.
    Bioorg Med Chem Lett; 2007 Jul 01; 17(13):3570-4. PubMed ID: 17485205
    [Abstract] [Full Text] [Related]

  • 2. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 3: synthesis of cyclopentanone and cyclohexanone intermediates for C-ring modification.
    Richardson TI, Dodge JA, Durst GL, Pfeifer LA, Shah J, Wang Y, Durbin JD, Krishnan V, Norman BH.
    Bioorg Med Chem Lett; 2007 Sep 01; 17(17):4824-8. PubMed ID: 17614275
    [Abstract] [Full Text] [Related]

  • 3. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 4: functionalization of the benzopyran A-ring.
    Norman BH, Richardson TI, Dodge JA, Pfeifer LA, Durst GL, Wang Y, Durbin JD, Krishnan V, Dinn SR, Liu S, Reilly JE, Ryter KT.
    Bioorg Med Chem Lett; 2007 Sep 15; 17(18):5082-5. PubMed ID: 17662603
    [Abstract] [Full Text] [Related]

  • 4. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 5: Combined A- and C-ring structure-activity relationship studies.
    Richardson TI, Dodge JA, Wang Y, Durbin JD, Krishnan V, Norman BH.
    Bioorg Med Chem Lett; 2007 Oct 15; 17(20):5563-6. PubMed ID: 17804226
    [Abstract] [Full Text] [Related]

  • 5. Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia.
    Norman BH, Dodge JA, Richardson TI, Borromeo PS, Lugar CW, Jones SA, Chen K, Wang Y, Durst GL, Barr RJ, Montrose-Rafizadeh C, Osborne HE, Amos RM, Guo S, Boodhoo A, Krishnan V.
    J Med Chem; 2006 Oct 19; 49(21):6155-7. PubMed ID: 17034120
    [Abstract] [Full Text] [Related]

  • 6. Discovery of potent ligands for estrogen receptor beta by structure-based virtual screening.
    Shen J, Tan C, Zhang Y, Li X, Li W, Huang J, Shen X, Tang Y.
    J Med Chem; 2010 Jul 22; 53(14):5361-5. PubMed ID: 20553023
    [Abstract] [Full Text] [Related]

  • 7. Tetrahydroisoquinolines as subtype selective estrogen agonists/antagonists.
    Chesworth R, Zawistoski MP, Lefker BA, Cameron KO, Day RF, Mangano FM, Rosati RL, Colella S, Petersen DN, Brault A, Lu B, Pan LC, Perry P, Ng O, Castleberry TA, Owen TA, Brown TA, Thompson DD, DaSilva-Jardine P.
    Bioorg Med Chem Lett; 2004 Jun 07; 14(11):2729-33. PubMed ID: 15125923
    [Abstract] [Full Text] [Related]

  • 8. Estrogen receptor ligands. II. Discovery of benzoxathiins as potent, selective estrogen receptor alpha modulators.
    Kim S, Wu JY, Birzin ET, Frisch K, Chan W, Pai LY, Yang YT, Mosley RT, Fitzgerald PM, Sharma N, Dahllund J, Thorsell AG, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.
    J Med Chem; 2004 Apr 22; 47(9):2171-5. PubMed ID: 15084115
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. New scaffolds for the design of selective estrogen receptor modulators.
    Martín-Santamaría S, Rodríguez JJ, de Pascual-Teresa S, Gordon S, Bengtsson M, Garrido-Laguna I, Rubio-Viqueira B, López-Casas PP, Hidalgo M, de Pascual-Teresa B, Ramos A.
    Org Biomol Chem; 2008 Oct 07; 6(19):3486-96. PubMed ID: 19082149
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis, pharmacological evaluation, and structure-activity relationships of benzopyran derivatives with potent SERM activity.
    Amari G, Armani E, Ghirardi S, Delcanale M, Civelli M, Caruso PL, Galbiati E, Lipreri M, Rivara S, Lodola A, Mor M.
    Bioorg Med Chem; 2004 Jul 15; 12(14):3763-82. PubMed ID: 15210143
    [Abstract] [Full Text] [Related]

  • 16. Androstenediol analogs as ER-beta-selective SERMs.
    Blizzard TA, Gude C, Morgan JD, Chan W, Birzin ET, Mojena M, Tudela C, Chen F, Knecht K, Su Q, Kraker B, Mosley RT, Holmes MA, Sharma N, Fitzgerald PM, Rohrer SP, Hammond ML.
    Bioorg Med Chem Lett; 2006 Feb 15; 16(4):834-8. PubMed ID: 16309907
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta.
    Minutolo F, Bertini S, Granchi C, Marchitiello T, Prota G, Rapposelli S, Tuccinardi T, Martinelli A, Gunther JR, Carlson KE, Katzenellenbogen JA, Macchia M.
    J Med Chem; 2009 Feb 12; 52(3):858-67. PubMed ID: 19128016
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.